Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Latest News about Jason Gerberry
Recent news which mentions Jason Gerberry
Xenon Pharmaceuticals May Have A Blockbuster Drug In Store, BofA Says
August 29, 2022
Tickers
XENE
Tags
XENE
BofA Securities
Initiation
From
Benzinga
Why This Teva Pharmaceuticals Analyst Is Turning Bullish 'The Most Room To Re-Rate'
August 05, 2022
Tickers
TEVA
Tags
BofA Securities
Price Target
Upgrades
From
Benzinga
Axsome Therapeutics Rallies 40% On FDA Product Label Proposal, But Analyst Remains Skeptical
June 27, 2022
Tickers
AXSM
Tags
Bank of America
Price Target
Small Cap
From
Benzinga
BofA Upgrades Teva Pharmaceutical On Possible Opioid Deal
May 17, 2022
Tickers
TEVA
Tags
Trading Ideas
opiods
Benzinga
From
Benzinga
BofA Initiates Arcellx With Buy On Its Novel Therapy Approach
March 01, 2022
Tickers
ACLX
Tags
Analyst Color
Market News
Analyst Ratings
From
Benzinga
BofA Downgrades Ionis After Vupanorsen Setback: Are There Upcoming Catalysts That Can Help The Stock?
February 01, 2022
Tickers
IONS
Tags
Analyst Ratings
Market News
pharmaceuticals
From
Benzinga
BofA Downgrades Alkermes After Stock Rally: 'We Don't See A Favorable Catalyst Pathway'
September 02, 2021
Tickers
ALKS
Tags
Health Care
General
BofA Securities
From
Benzinga
FibroGen Analyst Removes Roxadustat Sales From Model After AdCom Snub
July 16, 2021
Tickers
FGEN
Tags
Downgrades
Jason Gerberry
Analyst Color
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.